273 |
Glycemic Variability: How Do We Measure It and Why Is It Important?Glycemic Variability: How Do We Measure It and Why Is It Important?
Sunghwan Suh, Jae Hyeon KimSunghwan Suh, Jae Hyeon Kim
KMSID: 1084818 Diabetes Metab J. 2015;39(4):273-282. Published online 2015 August 17 DOI: http://dx.doi.org/10.4093/dmj.2015.39.4.273 |
|
283 |
Peripheral Arterial Disease in Patients with Type 2 Diabetes MellitusPeripheral Arterial Disease in Patients with Type 2 Diabetes Mellitus
Sang Youl Rhee, Young Seol KimSang Youl Rhee, Young Seol Kim
KMSID: 1084819 Diabetes Metab J. 2015;39(4):283-290. Published online 2015 August 17 DOI: http://dx.doi.org/10.4093/dmj.2015.39.4.283 |
|
291 |
Probiotics as Complementary Treatment for Metabolic DisordersProbiotics as Complementary Treatment for Metabolic Disorders
Mélanie Le Barz, Fernando F. Anhê, Thibaut V. Varin, Yves Desjardins, Emile Levy, Denis Roy, Maria C. Urdaci, André MaretteMélanie Le Barz, Fernando F. Anhê, Thibaut V. Varin, Yves Desjardins, Emile Levy, Denis Roy, Maria C. Urdaci, André Marette
KMSID: 1084820 Diabetes Metab J. 2015;39(4):291-303. Published online 2015 August 17 DOI: http://dx.doi.org/10.4093/dmj.2015.39.4.291 |
|
304 |
Effects of Sitagliptin on Insulin and Glucagon Levels in Type 2 Diabetes MellitusEffects of Sitagliptin on Insulin and Glucagon Levels in Type 2 Diabetes Mellitus
Ji Hyun KimJi Hyun Kim
KMSID: 1084821 Diabetes Metab J. 2015;39(4):304-306. Published online 2015 August 17 DOI: http://dx.doi.org/10.4093/dmj.2015.39.4.304 |
|
307 |
Current Status of Management in Type 2 Diabetes Mellitus at General Hospitals in South KoreaCurrent Status of Management in Type 2 Diabetes Mellitus at General Hospitals in South Korea
Jin-Hee Jung, Jung-Hwa Lee, Jin-Won Noh, Jeong-Eun Park, Hee-Sook Kim, Joo-Wha Yoo, Bok-Rye Song, Jeong-rim Lee, Myeong-Hee Hong, Hyang-Mi Jang, Young Na, Hyun-Joo Lee, Jeong-Mi Lee, Yang-Gyo Kang, Sun-Young Kim, Kang-Hee SimJin-Hee Jung, Jung-Hwa Lee, Jin-Won Noh, Jeong-Eun Park, Hee-Sook Kim, Joo-Wha Yoo, Bok-Rye Song, Jeong-rim Lee, Myeong-Hee Hong, Hyang-Mi Jang, Young Na, Hyun-Joo Lee, Jeong-Mi Lee, Yang-Gyo Kang, Sun-Young Kim, Kang-Hee Sim
KMSID: 1084822 Diabetes Metab J. 2015;39(4):307-315. Published online 2015 August 17 DOI: http://dx.doi.org/10.4093/dmj.2015.39.4.307 |
|
316 |
Maternal and Neonatal Outcomes in Korean Women with Type 1 and Type 2 DiabetesMaternal and Neonatal Outcomes in Korean Women with Type 1 and Type 2 Diabetes
Hee-Sook Kim, Hye-Jung Jang, Jeong-Eun Park, Moon-Young Kim, Sun-Young Ko, Sung-Hoon KimHee-Sook Kim, Hye-Jung Jang, Jeong-Eun Park, Moon-Young Kim, Sun-Young Ko, Sung-Hoon Kim
KMSID: 1084824 Diabetes Metab J. 2015;39(4):316-320. Published online 2015 August 17 DOI: http://dx.doi.org/10.4093/dmj.2015.39.4.316 |
|
321 |
Agreement between Framingham Risk Score and United Kingdom Prospective Diabetes Study Risk Engine in Identifying High Coronary Heart Disease Risk in North Indian PopulationAgreement between Framingham Risk Score and United Kingdom Prospective Diabetes Study Risk Engine in Identifying High Coronary Heart Disease Risk in North Indian Population
Dipika Bansal, Ramya S. R. Nayakallu, Kapil Gudala, Rajavikram Vyamasuni, Anil BhansaliDipika Bansal, Ramya S. R. Nayakallu, Kapil Gudala, Rajavikram Vyamasuni, Anil Bhansali
KMSID: 1084825 Diabetes Metab J. 2015;39(4):321-327. Published online 2015 July 8 DOI: http://dx.doi.org/10.4093/dmj.2015.39.4.321 |
|
328 |
Maximal Fat Oxidation Rate during Exercise in Korean Women with Type 2 Diabetes MellitusMaximal Fat Oxidation Rate during Exercise in Korean Women with Type 2 Diabetes Mellitus
Min Hwa Suk, Yeo-Jin Moon, Sung Woo Park, Cheol-Young Park, Yun A ShinMin Hwa Suk, Yeo-Jin Moon, Sung Woo Park, Cheol-Young Park, Yun A Shin
KMSID: 1084826 Diabetes Metab J. 2015;39(4):328-334. Published online 2015 July 8 DOI: http://dx.doi.org/10.4093/dmj.2015.39.4.328 |
|
335 |
Effects of 6-Month Sitagliptin Treatment on Insulin and Glucagon Responses in Korean Patients with Type 2 Diabetes MellitusEffects of 6-Month Sitagliptin Treatment on Insulin and Glucagon Responses in Korean Patients with Type 2 Diabetes Mellitus
Hae Kyung Yang, Borami Kang, Seung-Hwan Lee, Hun-Sung Kim, Kun-Ho Yoon, Bong-Yun Cha, Jae-Hyoung ChoHae Kyung Yang, Borami Kang, Seung-Hwan Lee, Hun-Sung Kim, Kun-Ho Yoon, Bong-Yun Cha, Jae-Hyoung Cho
KMSID: 1084827 Diabetes Metab J. 2015;39(4):335-341. Published online 2015 July 17 DOI: http://dx.doi.org/10.4093/dmj.2015.39.4.335 |
|
342 |
Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes MellitusPredictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus
Shusuke Yagi, Ken-ichi Aihara, Masashi Akaike, Daiju Fukuda, Hotimah Masdan Salim, Masayoshi Ishida, Tomomi Matsuura, Takayuki Ise, Koji Yamaguchi, Takashi Iwase, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Michio Shimabukuro, Toshio Matsumoto, Masataka SataShusuke Yagi, Ken-ichi Aihara, Masashi Akaike, Daiju Fukuda, Hotimah Masdan Salim, Masayoshi Ishida, Tomomi Matsuura, Takayuki Ise, Koji Yamaguchi, Takashi Iwase, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Michio Shimabukuro, Toshio Matsumoto, Masataka Sata
KMSID: 1084828 Diabetes Metab J. 2015;39(4):342-347. Published online 2015 July 21 DOI: http://dx.doi.org/10.4093/dmj.2015.39.4.342 |
|
348 |
Letter: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52)Letter: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52)
Dae Ho LeeDae Ho Lee
KMSID: 1084829 Diabetes Metab J. 2015;39(4):348-349. Published online 2015 August 17 DOI: http://dx.doi.org/10.4093/dmj.2015.39.4.348 |
|
350 |
Response: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52)Response: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52)
Sunghwan Suh, Gi Hyeon Seo, Chang Hee Jung, Mee-Kyoung Kim, Sang-Man Jin, You-Cheol Hwang, Byung-Wan Lee, Jae Hyeon KimSunghwan Suh, Gi Hyeon Seo, Chang Hee Jung, Mee-Kyoung Kim, Sang-Man Jin, You-Cheol Hwang, Byung-Wan Lee, Jae Hyeon Kim
KMSID: 1084830 Diabetes Metab J. 2015;39(4):350-351. Published online 2015 August 17 DOI: http://dx.doi.org/10.4093/dmj.2015.39.4.350 |
|